Cargando…

Effect Of α2-Adrenergic Agonists And Antagonists On Cytokine Release From Human Lung Macrophages Cultured In Vitro

The most trusted hypothesis to explain how α2-adrenergic agonists may preserve pulmonary functions in critically ill patients is that they directly act on macrophages by interfering with an autocrine/paracrine adrenergic system that controls cytokine release through locally synthetized noradrenaline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piazza, O., Staiano, R.I., De Robertis, E., Conti, G., Di Crescenzo, V., Loffredo, S., Marone, G., Marinosci, G. Zito, Cataldi, M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università di Salerno 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120752/ https://www.ncbi.nlm.nih.gov/pubmed/27896229

Ejemplares similares

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Dopamine Use in Intensive Care: Are We Ready to Turn it Down?
por: Marinosci, Geremia Zito, et al.
Publicado: (2012)

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020)

Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat
por: Bölter, Christian, et al.
Publicado: (2019)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone
por: Støve, Svein Isungset, et al.
Publicado: (2022)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact
por: De Robertis, Edoardo, et al.
Publicado: (2016)

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor
por: Warne, Tony, et al.
Publicado: (2011)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Vaptans and Hyponatremia in Critical Patients
por: D’Auria, David, et al.
Publicado: (2012)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

β-Adrenergic Agonist and Antagonist Regulation of Autophagy in HepG2 Cells, Primary Mouse Hepatocytes, and Mouse Liver
por: Farah, Benjamin L., et al.
Publicado: (2014)

Antispasmodic and bronchorelaxant activities of Salsola imbricata are mediated through dual Ca(+2) antagonistic and β-adrenergic agonistic effects
por: Aslam, Naveed, et al.
Publicado: (2017)

Human lung and monocyte-derived macrophages differ with regard to the effects of β(2)-adrenoceptor agonists on cytokine release
por: Victoni, Tatiana, et al.
Publicado: (2017)

Suppression of the cough reflex by α(2)-adrenergic receptor agonists in the rabbit
por: Cinelli, Elenia, et al.
Publicado: (2013)

Structural basis of agonist specificity of α(1A)-adrenergic receptor
por: Su, Minfei, et al.
Publicado: (2023)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Neuronal ensembles sufficient for recovery sleep and the sedative actions of α(2) adrenergic agonists
por: Zhang, Zhe, et al.
Publicado: (2015)

Partial agonist activity of α(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3
por: Gao, Xianlong, et al.
Publicado: (2018)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

Altered pharmacological effects of adrenergic agonists during hypothermia
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2016)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

Simulations of Biased Agonists in the β(2) Adrenergic Receptor with Accelerated Molecular Dynamics
por: Tikhonova, Irina G., et al.
Publicado: (2013)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

The Specific α1-Adrenergic Receptor Antagonist Prazosin Influences the Urine Proteome
por: Zhao, Mindi, et al.
Publicado: (2016)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Effect of beta-adrenergic agonist on alveolar fluid clearance in rats
por: Qiu, H, et al.
Publicado: (2005)

The Effects of Inhaled β-Adrenergic Agonists in Transient Tachypnea of the Newborn
por: Keleş, Esengul, et al.
Publicado: (2016)

Adrenergic receptor agonists/hydrocortisone: Lack of efficacy: case report
Publicado: (2021)

Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment
por: Braile, Mariantonia, et al.
Publicado: (2021)

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection
por: Nizari, Shereen, et al.
Publicado: (2016)

In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
por: Piwnica, David, et al.
Publicado: (2018)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages
por: Tan, Yao, et al.
Publicado: (2022)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
por: Malhotra, Neena, et al.
Publicado: (2013)

Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
por: Root-Bernstein, Robert
Publicado: (2022)

Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
por: Lee, Sehan, et al.
Publicado: (2017)

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
por: Wolter, Jennifer K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qu7klhu574ca1em7apoeatcnv7